Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,973,664 papers from all fields of science
Search
Sign In
Create Free Account
aclidinium
Known as:
(3-Carbamoyl-3,3-diphenylpropyl)ethyldimethylammonium
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
30 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza]
aclidinium bromide
Narrower (1)
Tudorza
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
N. Horita
,
A. Goto
,
+4 authors
T. Kaneko
Cochrane Database of Systematic Reviews
2017
Corpus ID: 205211007
BACKGROUND Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta…
Expand
Highly Cited
2017
Highly Cited
2017
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
H. Watz
,
T. Troosters
,
+7 authors
E. Garcia Gil
International Journal of COPD
2017
Corpus ID: 3419115
The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of…
Expand
2016
2016
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
M. Miravitlles
,
K. Chapman
,
F. Chuecos
,
A. Ribera
,
E. G. Gil
International Journal of COPD
2016
Corpus ID: 15361266
Background Patients with chronic obstructive pulmonary disease (COPD) experience respiratory symptoms, which impair quality of…
Expand
Review
2015
Review
2015
Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines
H. Kankaanranta
,
T. Harju
,
+6 authors
L. Lehtimäki
Basic & Clinical Pharmacology & Toxicology
2015
Corpus ID: 12991551
The Finnish Medical Society Duodecim initiated and managed the update of the Finnish national guideline for chronic obstructive…
Expand
Review
2014
Review
2014
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
Kayleigh Kew
,
S. Dias
,
C. Cates
Cochrane Database of Systematic Reviews
2014
Corpus ID: 1749781
BACKGROUND Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving…
Expand
Highly Cited
2013
Highly Cited
2013
Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled…
J. Beier
,
A. Kirsten
,
+4 authors
E. G. Gil
COPD
2013
Corpus ID: 18309392
Abstract Background: This randomized, double-blind, Phase IIIb study evaluated the 24-hour bronchodilatory efficacy of aclidinium…
Expand
2013
2013
ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
S. Rennard
,
P. Scanlon
,
+4 authors
C. Caracta
Clinical drug investigation
2013
Corpus ID: 38059257
Background and ObjectivesAclidinium bromide is a long-acting muscarinic antagonist approved for the long-term maintenance…
Expand
Highly Cited
2011
Highly Cited
2011
Aclidinium inhibits human lung fibroblast to myofibroblast transition
J. Milara
,
A. Serrano
,
+4 authors
J. Cortijo
Thorax
2011
Corpus ID: 14617076
Background Fibroblast to myofibroblast transition is believed to contribute to airway remodelling in lung diseases such as asthma…
Expand
Highly Cited
2010
Highly Cited
2010
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways
J. Cortijo
,
M. Mata
,
+4 authors
E. Morcillo
European Respiratory Journal
2010
Corpus ID: 10908649
Mucus hypersecretion and mucin MUC5AC overexpression are pathological features of chronic obstructive pulmonary disease (COPD…
Expand
Review
2008
Review
2008
Novel long‐acting bronchodilators for COPD and asthma
M. Cazzola
,
M. Matera
British Journal of Pharmacology
2008
Corpus ID: 5842570
An important step in simplifying asthma and chronic obstructive pulmonary disease (COPD) management and improving adherence with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE